MTRI insider filings
InMed Pharmaceuticals Inc. — 16 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-12. Screen MTRI transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 16 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing by 2 insiders — 2,640 shares, $34,572 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 2,640 shares @ $13.10 ($34,572) by ADAR1 Capital Management, LLC, filed 2026-11-09.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC — 10% owner & Schneeberger Daniel — 10% owner | 1 | 1 leg · 2,640 sh · $34,572 | — | — |
| Bruno Julianne — Director | 2 | — | — | 1 |
| Divis Gregory J — See Remarks, Director | 2 | — | — | 1 |
| Hagen Brett R — See Remarks | 2 | — | — | 1 |
| Pernice Michelle Patricia — Director | 2 | — | — | 1 |
| Sandler Laura Lee — Director | 2 | — | — | 1 |
| Seurer Jerad G. — See Remarks | 2 | — | — | 1 |
| Shegog Todd — Director | 2 | — | — | 1 |
| Fairmount Funds Management LLC — 10% owner & Fairmount Healthcare Fund II L.P. — 10% owner & Kiselak Tomas — 10% owner & Harwin Peter Evan — 10% owner | 1 | — | — | — |
Recent insider filings — InMed Pharmaceuticals Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Shegog Todd — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Pernice Michelle Patricia — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Bruno Julianne — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Divis Gregory J — See Remarks, Director | Grant/award (A): 1,560,599 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Hagen Brett R — See Remarks | Grant/award (A): 171,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Sandler Laura Lee — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | Seurer Jerad G. — See Remarks | Grant/award (A): 257,000 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 3 | Bruno Julianne — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Pernice Michelle Patricia — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Sandler Laura Lee — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Shegog Todd — Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Fairmount Funds Management LLC — 10% owner Fairmount Healthcare Fund II L.P. — 10% owner Kiselak Tomas — 10% owner Harwin Peter Evan — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Seurer Jerad G. — See Remarks | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Hagen Brett R — See Remarks | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 3 | Divis Gregory J — See Remarks, Director | Holdings only — no transactions reported | EDGAR |
| 2026-11-09 | 4 | ADAR1 Capital Management, LLC — 10% owner Schneeberger Daniel — 10% owner | Purchase (P): 2,640 @ $13.10 | EDGAR |
Recent 8-K events — InMed Pharmaceuticals Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-20 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-16 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.05 — Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics 5.06 — Change in Shell Company Status 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-05 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-03 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-18 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-22 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MTRI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs